Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

17
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
17
Autoimmune Disorders01:29

Autoimmune Disorders

2.3K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.3K
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

49
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
49
T Cell Types and Functions01:24

T Cell Types and Functions

3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Childhood to Adult Neurodevelopment in Gene-Expanded Huntington's Disease (ChANGE-HD): A prospective longitudinal neurodevelopmental study of Huntington's disease.

PloS one·2026
Same author

Non-MRI biomarkers should be accepted to guide treatment escalation in MS: NO.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Childhood to Adult Neurodevelopment in Gene-Expanded Huntington's Disease (ChANGE-HD) study protocol: A Prospective Longitudinal Neurodevelopmental Study of Huntington's Disease.

medRxiv : the preprint server for health sciences·2025
Same author

A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MS.

Neurology. Clinical practice·2025
Same author

No Evidence of Early Developmental Delay in Juvenile-Onset Huntington's Disease Patients.

Movement disorders clinical practice·2024
Same author

Mutant Huntingtin Drives Development of an Advantageous Brain Early in Life: Evidence in Support of Antagonistic Pleiotropy.

Annals of neurology·2024

Related Experiment Video

Updated: Apr 28, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K

Iron and multiple sclerosis.

James M Stankiewicz1, Mohit Neema1, Antonia Ceccarelli1

  • 1Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Partners Multiple Sclerosis Center, Brookline, MA, USA.

Neurobiology of Aging
|June 16, 2014
PubMed
Summary
This summary is machine-generated.

This review explores iron's role in multiple sclerosis (MS) pathophysiology, examining brain iron deposition and its connection to disease progression. It also reviews MRI techniques and potential iron chelation therapies for MS.

Keywords:
AntioxidantBrainChelationIronMultiple sclerosis

More Related Videos

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
04:48

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII

Published on: May 4, 2020

9.5K
Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

1.5K

Related Experiment Videos

Last Updated: Apr 28, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

9.7K
Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
04:48

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII

Published on: May 4, 2020

9.5K
Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

1.5K

Area of Science:

  • Neuroscience
  • Neurology
  • Biochemistry

Background:

  • Iron is vital for central nervous system function.
  • Altered iron metabolism can cause neuronal death and brain iron deposition.
  • Brain iron deposition is linked to aging and neurological diseases like multiple sclerosis (MS).

Purpose of the Study:

  • To review the role of iron in multiple sclerosis (MS) pathophysiology.
  • To discuss magnetic resonance imaging (MRI) techniques for characterizing brain iron in MS.
  • To provide an overview of iron chelation and antioxidant therapies for MS.

Main Methods:

  • Literature review focusing on iron metabolism in the central nervous system.
  • Analysis of studies linking brain iron deposition to MS.
  • Review of conventional and advanced MRI techniques for iron detection.
  • Survey of clinical trials involving iron chelation or antioxidant therapies in MS.

Main Results:

  • Iron's role in MS pathophysiology is complex, potentially acting as a mediator rather than just an epiphenomenon.
  • MRI techniques are crucial for assessing brain iron deposition in MS patients.
  • Current evidence is insufficient to support routine clinical use of iron chelation in MS.

Conclusions:

  • Iron dysregulation is implicated in MS pathogenesis.
  • Advanced MRI aids in understanding iron's impact in MS.
  • Further research is needed to validate iron-targeted therapies for MS.